ONCIN — Oncoinvent ASA Income Statement
0.000.00%
Last trade - 00:00- NOK1.97m
- -NOK63.99m
- NOK28.07m
Annual income statement for Oncoinvent ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.774 | 0.389 | 0.354 | 0.848 | 28.1 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 315 | 306 | 192 | 152 | 186 |
| Operating Profit | -314 | -306 | -192 | -151 | -158 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -309 | -302 | -190 | -139 | -155 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -309 | -302 | -190 | -139 | -155 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -309 | -302 | -190 | -139 | -155 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -309 | -302 | -190 | -139 | -155 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -2,586 | -2,506 | -852 | -253 | -125 |